S&P ASX All Technology

3,102.60

0.47%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GAP

Pharmagap Inc. (GAP)

Pharmagap Inc.

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:GAP

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
08/05/2013	00:26	PR Newswire (Canada)	PharmaGap Notified of Cease Trade Order	TSXV:GAP	Pharmagap Inc.
07/05/2013	04:47	PR Newswire (Canada)	TSX Venture Exchange Cease Trade Order	TSXV:GAP	Pharmagap Inc.
06/05/2013	22:20	PR Newswire (Canada)	IIROC Trading Halt - GAP	TSXV:GAP	Pharmagap Inc.
06/05/2013	22:20	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - GAP	TSXV:GAP	Pharmagap Inc.
07/02/2013	00:00	PR Newswire (Canada)	PharmaGap Receives Notice of Pending Transfer to NEX Exchange	TSXV:GAP	Pharmagap Inc.
05/02/2013	03:11	PR Newswire (Canada)	L’OCRCVM permet la reprise de la négociation - GAP	TSXV:GAP	Pharmagap Inc.
05/02/2013	03:11	PR Newswire (Canada)	IIROC Trading Resumption - GAP	TSXV:GAP	Pharmagap Inc.
05/02/2013	02:32	PR Newswire (Canada)	PharmaGap Provides Update on Status	TSXV:GAP	Pharmagap Inc.
05/02/2013	01:11	PR Newswire (Canada)	IIROC Trading Halt - GAP	TSXV:GAP	Pharmagap Inc.
05/02/2013	01:11	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - GAP	TSXV:GAP	Pharmagap Inc.
02/08/2012	21:03	PR Newswire (Canada)	PharmaGap Shareholders Approve License to Clinical Value Corporation at Annual General Meeting	TSXV:GAP	Pharmagap Inc.
05/07/2012	22:00	PR Newswire (Canada)	PharmaGap Receives Independent Value Opinion and Support of Independent Committee for Proposed License to Clinical Value Corpor	TSXV:GAP	Pharmagap Inc.
05/06/2012	22:30	PR Newswire (Canada)	PharmaGap Updates Lead Drug Status and Potential Sale	TSXV:GAP	Pharmagap Inc.
24/05/2012	22:30	PR Newswire (Canada)	PharmaGap announces conditional approval to license its lead drug and related intellectual property	TSXV:GAP	Pharmagap Inc.
21/01/2012	07:19	Marketwired Canada	PharmaGap Completes $231,000 Private Placement	TSXV:GAP	Pharmagap Inc.
12/01/2012	07:21	Marketwired Canada	PharmaGap Completes $70,774 Private Placement	TSXV:GAP	Pharmagap Inc.
21/12/2011	23:00	Marketwired Canada	PharmaGap Completes In Vivo Study Protocol in Ovarian Cancer	TSXV:GAP	Pharmagap Inc.
05/12/2011	23:00	Marketwired Canada	PharmaGap Completes $634,210 Private Placement	TSXV:GAP	Pharmagap Inc.
29/11/2011	07:48	Marketwired	PharmaGap Completes Initial Closing of Private Placement	TSXV:GAP	Pharmagap Inc.
26/11/2011	00:00	Marketwired	PharmaGap Liposomal Formulations Achieve Key Milestones for Clinical Trials	TSXV:GAP	Pharmagap Inc.
16/11/2011	00:00	Marketwired	PharmaGap Announces Start of Definitive Animal Efficacy Study Required to Proceed to Clinical Trials	TSXV:GAP	Pharmagap Inc.
27/10/2011	23:00	Marketwired	PharmaGap Sets Time for in Vivo Tests	TSXV:GAP	Pharmagap Inc.
24/10/2011	23:00	Marketwired	PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials	TSXV:GAP	Pharmagap Inc.
22/10/2011	07:00	Marketwired	PharmaGap Completes Placement of Equity Units	TSXV:GAP	Pharmagap Inc.
22/10/2011	07:00	Marketwired Canada	PharmaGap Completes Placement of Equity Units	TSXV:GAP	Pharmagap Inc.
19/10/2011	23:00	Marketwired	PharmaGap Completes Manufacturer Site Audits Required for Clinical Trial Submission	TSXV:GAP	Pharmagap Inc.
03/10/2011	23:38	Marketwired	PharmaGap Files Provisional Patent Application for Liposomal Formulations of GAP-107B8	TSXV:GAP	Pharmagap Inc.
01/10/2011	00:00	Marketwired	PharmaGap to Host Investor Conference Call	TSXV:GAP	Pharmagap Inc.
29/09/2011	22:43	Marketwired	PharmaGap Adds to Patent Portfolio For GAP-107B8 Cancer Drug; Expands Claims	TSXV:GAP	Pharmagap Inc.
22/09/2011	22:44	Marketwired	PharmaGap Completes Initial Close of Private Placement	TSXV:GAP	Pharmagap Inc.